A Formulation and Evaluation of Gastro-retentive In-Situ Gel of Anti-Ulcer Drug Misoprostol

Lucky Vasave; Shivraj Jadhav; Rushikesh Bachhav; Sunil Mahajan; Deepak Sonawane

doi:10.56782/pps.441

Published : 2025-08-07

No. 2025 (Early Access)

A Formulation and Evaluation of Gastro-retentive In-Situ Gel of Anti-Ulcer Drug Misoprostol

Lucky Vasave

Shivraj Jadhav

Rushikesh Bachhav

Sunil Mahajan

Deepak Sonawane

DOI: https://doi.org/10.56782/pps.441

Abstract

Background: Peptic ulcer disease (PUD) is a prevalent gastrointestinal disorder caused by an imbalance between protective and aggressive gastric factors. Misoprostol, a synthetic prostaglandin E1 analogue, is effective in ulcer management but has limitations such as rapid metabolism, low bioavailability, and frequent dosing. This study aimed to develop a gastro-retentive in-situ gel of misoprostol to enhance gastric retention and controlled drug release. Methods: The in-situ gel was formulated using gellan gum and calcium carbonate as key excipients. A 3² factorial design was employed to optimize floating lag time and in-vitro drug release. The formulations were evaluated for pH, viscosity, gelling capacity, floating behavior, drug content, and in-vitro drug release using a USP Type II dissolution apparatus in simulated gastric fluid (pH 1.2). Stability studies were conducted under accelerated conditions (40°C ± 2°C / 75% ± 5% RH) for six months. Results: The optimized formulation (LF5) exhibited a pH of 6.6, a floating lag time of 18.03 seconds, and a total floating time exceeding 6 hours, ensuring prolonged gastric retention. Drug content analysis confirmed 93.04% uniformity across batches. In-vitro drug release showed sustained drug release of 93.04% over 240 minutes. Stability studies demonstrated no significant changes in pH, floating behavior, or drug content, confirming formulation robustness. Conclusion: The gastro-retentive in-situ gel of misoprostol successfully enhanced gastric retention and controlled drug release. The optimized formulation exhibited rapid buoyancy, prolonged retention, and stability, making it a promising approach for improving misoprostol’s therapeutic efficacy in peptic ulcer management.

Keywords:

Peptic ulcer disease, Gastro-retentive in-situ gel, Misoprostol, Gellan gum, Calcium carbonate, Floating drug delivery, Controlled release, Stability study

Similar Articles

Elżbieta Gniazdowska, Edyta Gilant, Katarzyna Buś-Kwaśnik, ICH M10 guideline - a harmonized global approach to bioanalysis , Prospects in Pharmaceutical Sciences: Vol. 21 No. 3 (2023)
Ali İmran Korkmaz, Celal Bal, Emre Cem Eraslan, Mustafa Sevindik, Hasan Akgul, Biological activities of Agrocybe praecox (spring fieldcap mushroom) , Prospects in Pharmaceutical Sciences: Vol. 21 No. 4 (2023)
Grażyna Kubiak-Tomaszewska, Jan Pachecka, Jacek Łukaszkiewicz, Piotr Tomaszewski, MECHANISMS OF RECEPTOR-DEPENDENT REGULATION OF BILE ACID AND XENOBIOTIC METABOLISM. THE ROLE OF CYP3A4 EXPRESSION IN THE SAFETY AND EFFECTIVENESS OF PHARMACOTHERAPY , Prospects in Pharmaceutical Sciences: Vol. 14 No. 9 (2016)
Nikolay Akatyev, Albina Samigolla, Sun protection properties and photostability of aqueous extracts of dandelion (Taraxacum officinale L.). , Prospects in Pharmaceutical Sciences: Vol. 22 No. 4 (2024)
Szymon Barczak, Zuzanna Hertz, Barbara Badura, The role of serum procalcitonin as a diagnostic marker in patients with dengue: a review , Prospects in Pharmaceutical Sciences: Vol. 23 No. 2 (2025)
Sylwester Krukowski, SYNTHESIS AND STRUCTURAL STUDIES OF CALCIUM HYDROXYAPATITES MODIFIED WITH AMINO ACIDS , Prospects in Pharmaceutical Sciences: Vol. 11 No. 7 (2013)
Sylwia Osowska, Joanna Regulska, Lipid peroxidation markers used in parenteral nutrition , Prospects in Pharmaceutical Sciences: Vol. 21 No. 4 (2023)
Mega Yulia, Yufri Aldi, Hansen Nasif, Fatma Sri Wahyuni, Dachriyanus, Immunoactivities of fractions of Elephantopus scaber linn leaf in NK cells, CD8+ T cells, and perforin , Prospects in Pharmaceutical Sciences: Vol. 23 No. 1 (2025)
Anna Zgadzaj, PHOTOGENOTOXICITY IN IN VITRO STUDIES AND IN BACTERIAL TESTS IN THE YEARS 2013-2018 COMPARED WITH EARLIER PUBLICATIONS IN LIGHT OF CHANGES IN LEGAL REGULATIONS , Prospects in Pharmaceutical Sciences: Vol. 16 No. 3 (2018)
Dariusz Łaszczych, Aleksandra Czernicka, Kornelia Kędziora-Kornatowska, Interaction between warfarin and selected superfoods: a comprehensive review of potential mechanisms and their clinical significance , Prospects in Pharmaceutical Sciences: Vol. 22 No. 3 (2024)

<< < 5 6 7 8 9 10 11 12 13 14 > >>

You may also start an advanced similarity search for this article.

Details

References

Statistics

Authors

Download files

PDF

Citation rules

Vasave, L., Jadhav, S., Bachhav, R., Mahajan, S., & Sonawane, D. (2025). A Formulation and Evaluation of Gastro-retentive In-Situ Gel of Anti-Ulcer Drug Misoprostol. Prospects in Pharmaceutical Sciences, (2025 (Early Access). https://doi.org/10.56782/pps.441

Altmetric indicators

Cited by / Share

Licence

This work is licensed under a Creative Commons Attribution 4.0 International License.

References

(1) Yegen, B. C. Lifestyle and Peptic Ulcer Disease. CPD 2018, 24 (18), 2034–2040. DOI:10.2174/1381612824666180510092303. DOI: https://doi.org/10.2174/1381612824666180510092303

(2) Xie, X.; Ren, K.; Zhou, Z.; Dang, C.; Zhang, H. The Global, Regional and National Burden of Peptic Ulcer Disease from 1990 to 2019: A Population-Based Study. BMC Gastroenterol 2022, 22 (1), 58. DOI:10.1186/s12876-022-02130-2. DOI: https://doi.org/10.1186/s12876-022-02130-2

(3) Shell, E. J. Pathophysiology of Peptic Ulcer Disease. PA Clinics 2021, 6 (4), 603–611. DOI:10.1016/j.cpha.2021.05.005. DOI: https://doi.org/10.1016/j.cpha.2021.05.005

(4) Srivastav, Y.; Kumar, V.; Srivastava, Y.; Kumar, M. Peptic Ulcer Disease (PUD), Diagnosis, and Current Medication-Based Management Options: Schematic Overview. JAMPS 2023, 25 (11), 14–27. DOI:10.9734/jamps/2023/v25i11651. DOI: https://doi.org/10.9734/jamps/2023/v25i11651

(5) Lee, S. P.; Sung, I.-K.; Kim, J. H.; Lee, S.-Y.; Park, H. S.; Shim, C. S. Risk Factors for the Presence of Symptoms in Peptic Ulcer Disease. Clin Endosc 2017, 50 (6), 578–584. DOI:10.5946/ce.2016.129. DOI: https://doi.org/10.5946/ce.2016.129

(6) Dunlap, J. J.; Patterson, S. Peptic Ulcer Disease. Gastroenterol Nur 2019, 42 (5), 451–454. DOI:10.1097/SGA.0000000000000478. DOI: https://doi.org/10.1097/SGA.0000000000000478

(7) Vigani, B.; Rossi, S.; Sandri, G.; Bonferoni, M. C.; Caramella, C. M.; Ferrari, F. Recent Advances in the Development of In Situ Gelling Drug Delivery Systems for Non-Parenteral Administration Routes. Pharmaceutics 2020, 12 (9), 859. DOI:10.3390/pharmaceutics12090859. DOI: https://doi.org/10.3390/pharmaceutics12090859

(8) Bilal Jilani Shaikh; Indrayani D Raut; Manojkumar M Nitalikar; Shrinivas K. Mohite; Chandrakant S. Magdum. An Overview on In-Situ Gel: A Novel Drug Delivery System. Int J Pharm Sci Nanotechnol 2021, 15 (5), 6180–6189. DOI:10.37285/ijpsn.2022.15.5.10. DOI: https://doi.org/10.37285/ijpsn.2022.15.5.10

(9) Wu, Y.; Liu, Y.; Li, X.; Kebebe, D.; Zhang, B.; Ren, J.; Lu, J.; Li, J.; Du, S.; Liu, Z. Research Progress of In-Situ Gelling Ophthalmic Drug Delivery System. Asian J Pharm Sci 2019, 14 (1), 1–15. DOI:10.1016/j.ajps.2018.04.008. DOI: https://doi.org/10.1016/j.ajps.2018.04.008

(10) Kamada, T.; Satoh, K.; Itoh, T.; Ito, M.; Iwamoto, J.; Okimoto, T.; Kanno, T.; Sugimoto, M.; Chiba, T.; Nomura, S.; Mieda, M.; Hiraishi, H.; Yoshino, J.; Takagi, A.; Watanabe, S.; Koike, K. Evidence-Based Clinical Practice Guidelines for Peptic Ulcer Disease 2020. J Gastroenterol 2021, 56 (4), 303–322. DOI:10.1007/s00535-021-01769-0. DOI: https://doi.org/10.1007/s00535-021-01769-0

(11) Jadhav, S. P.; Dhakad, P. K.; Gupta, T.; Gilhotra, R. Formulation Development and Evaluation of Paliperidone Nanosuspension for Solubility Enhancement. Int J App Pharm 2024, 173–181. DOI:10.22159/ijap.2024v16i4.51218. DOI: https://doi.org/10.22159/ijap.2024v16i4.51218

(12) Wu, H.; Marwah, S.; Wang, P.; Wang, Q.; Chen, X. Misoprostol for Medical Treatment of Missed Abortion: A Systematic Review and Network Meta-Analysis. Sci Rep 2017, 7 (1), 1664. DOI:10.1038/s41598-017-01892-0. DOI: https://doi.org/10.1038/s41598-017-01892-0

(13) Raymond, E. G.; Harrison, M. S.; Weaver, M. A. Efficacy of Misoprostol Alone for First-Trimester Medical Abortion: A Systematic Review. Obstet Gynecol 2019, 133 (1), 137–147. DOI:10.1097/AOG.0000000000003017. DOI: https://doi.org/10.1097/AOG.0000000000003017

(14) Salzberger, H.; Maul, H. Gutes Misoprostol, böses Misoprostol – oder wie ich es schaffe, ein Medikament mehr als 100-mal teurer zu machen? Geburtshilfe Frauenheilkd 2022, 82 (05), 480–486. DOI:10.1055/a-1664-0036. DOI: https://doi.org/10.1055/a-1664-0036

(15) Szpot, P.; Wachełko, O.; Zawadzki, M. Determination of Prostaglandins (Carboprost, Cloprostenol, Dinoprost, Dinoprostone, Misoprostol, Sulprostone) by UHPLC-MS/MS in Toxicological Investigations. Toxics 2023, 11 (10), 802. DOI:10.3390/toxics11100802. DOI: https://doi.org/10.3390/toxics11100802

(16) Da Silva, J. W. V.; Duarte, M. L.; Ribeiro, J. I.; Kishishita, J.; Souza, A. T. M.; Leal, L. B.; De Castro, W. V.; De Santana, D. P.; Bedor, D. C. G. Development and Validation of a Stability‐indicating Method, Structural Elucidation of New Degradation Products from Misoprostol by LC–MS Time‐of‐flight, and an Ex Vivo Study of Vaginal Permeation. Biomed Chromatogr 2024, 38 (8), e5897. DOI:10.1002/bmc.5897. DOI: https://doi.org/10.1002/bmc.5897

(17) Rojek, B.; Wesolowski, M. A Combined Differential Scanning Calorimetry and Thermogravimetry Approach for the Effective Assessment of Drug Substance-Excipient Compatibility. J Therm Anal Calorim 2023, 148 (3), 845–858. DOI:10.1007/s10973-022-11849-9. DOI: https://doi.org/10.1007/s10973-022-11849-9

(18) Załuski, D.; Dubis, B.; Budzyński, W.; Jankowski, K. Applicability of the 35–2 Fractional Factorial Design in Determining the Effects of Cultivation Factors on Hulless Oat. Agronomy 2016, 108 (1), 205–218. DOI:10.2134/agronj2014.0607. DOI: https://doi.org/10.2134/agronj2014.0607

(19) M, S. S.; Priya, S.; Maxwell, A. Formulation and Evaluation of Novel in Situ Gel of Lafutidine for Gastro-Retentive Drug Delivery. Asian J Pharm Clin Res 2018, 11 (8), 88. DOI:10.22159/ajpcr.2018.v11i8.25582. DOI: https://doi.org/10.22159/ajpcr.2018.v11i8.25582

(20) S. N. Shaikh; V. G. Jain; G. J. Khan. Design, Development and Evaluation of Gastric Floating in-Situ Gel of Piroxicam. IJPSR 11 (7).

(21) Juthi, A. Z.; Li, F.; Wang, B.; Alam, M. M.; Talukder, M. E.; Qiu, B. pH-Responsive Super-Porous Hybrid Hydrogels for Gastroretentive Controlled-Release Drug Delivery. Pharmaceutics 2023, 15 (3), 816. DOI:10.3390/pharmaceutics15030816. DOI: https://doi.org/10.3390/pharmaceutics15030816

(22) R., V.; Priya, S.; Jyothi, D.; James, J. P. Formulation and Evaluation of Novel in Situ Gel of Lafutidine for Gastro-Retentive Drug Delivery. Int J App Pharm 2024, 76–85. DOI:10.22159/ijap.2024v16i2.49033.

(23) Soni, A.; Mahesh Kumar Kataria. Formulation and Evaluation of Floating in Situ Gel of Omeprazole Magnesium for Oral Drug Delivery System. Asian J Pharm Clin Res 2021, 44–52. DOI:10.22159/ajpcr.2021.v14i9.42231. DOI: https://doi.org/10.22159/ajpcr.2021.v14i9.42231

(24) Siripruekpong, W.; Praparatana, R.; Issarachot, O.; Wiwattanapatapee, R. Simultaneous Delivery of Curcumin and Resveratrol via In Situ Gelling, Raft-Forming, Gastroretentive Formulations. Pharmaceutics 2024, 16 (5), 641. DOI:10.3390/pharmaceutics16050641. DOI: https://doi.org/10.3390/pharmaceutics16050641

(25) Mahmoud, D. B.; Shukr, M. H.; ElMeshad, A. N. Gastroretentive Cosolvent-Based In Situ Gel as a Promising Approach for Simultaneous Extended Delivery and Enhanced Bioavailability of Mitiglinide Calcium. Journal of Pharmaceutical Sciences 2019, 108 (2), 897–906. DOI:10.1016/j.xphs.2018.09.020.

(26) Kathpalia, H.; Salunkhe, S.; Juvekar, S. Formulation of Gastroretentive Sustained Release Floating in Situ Gelling Drug Delivery System of Solubility Enhanced Curcumin-Soy Lecithin Complex. J Drug Del Sci Tech 2019, 53, 101205. DOI:10.1016/j.jddst.2019.101205.

(27) Shabaraya, Ar.; T Ashwini, T.; Vineetha, K. Formulation and Evaluation of Gastroretentive In Situ Gelling System of Ketoprofen. Eur Pharm J 2023, 70 (2), 10–19. DOI:10.2478/afpuc-2023-0018. DOI: https://doi.org/10.2478/afpuc-2023-0018

(28) Malviya, V.; Tawar, M.; Burange, P.; Bairagi, R. Preparation and Characterization of Gastroreten-Tive Sustained Release In-Situ Gel of Lafutidine. IJPSN 2022, 15 (6), 6216–6228. DOI:10.37285/ijpsn.2022.15.6.4. DOI: https://doi.org/10.37285/ijpsn.2022.15.6.4

(29) Mahmoud, D. B.; Shukr, M. H.; ElMeshad, A. N. Gastroretentive Cosolvent-Based In Situ Gel as a Promising Approach for Simultaneous Extended Delivery and Enhanced Bioavailability of Mitiglinide Calcium. J Pharm Sci 2019, 108 (2), 897–906. DOI:10.1016/j.xphs.2018.09.020. DOI: https://doi.org/10.1016/j.xphs.2018.09.020

(30) vijayashree R.; Divya Jyothi; Jainey P. James. Formulation and Characterisation of Gastroretentive in Situ Gel Loaded with Glycyrrhiza Glabra L. Extract for Gastric Ulcer. Int J App Pharm 2024, 76–85. DOI:10.22159/ijap.2024v16i2.49033. DOI: https://doi.org/10.22159/ijap.2024v16i2.49033

(31) Department of Biological Science, Faculty of Science and Technology, Bingham University, Karu, Nigeria; Anyanwu, N. Development and Evaluation of in Situ Gelling Gastroretentive Formulations of Meloxicam. UJPR 2017, 2 (3), 11–14. DOI:10.22270/ujpr.v2i3.R3. DOI: https://doi.org/10.22270/ujpr.v2i3.R3

(32) Kim, J. H.; Song, S. H.; Joo, S. H.; Park, G. H.; Weon, K.-Y. Formulation of a Gastroretentive In Situ Oral Gel Containing Metformin HCl Based on DoE. Pharmaceutics 2022, 14 (9), 1777. DOI:10.3390/pharmaceutics14091777. DOI: https://doi.org/10.3390/pharmaceutics14091777

(33) Kathpalia, H.; Salunkhe, S.; Juvekar, S. Formulation of Gastroretentive Sustained Release Floating in Situ Gelling Drug Delivery System of Solubility Enhanced Curcumin-Soy Lecithin Complex. J Drug Del Sci Tech 2019, 53, 101205. DOI:10.1016/j.jddst.2019.101205. DOI: https://doi.org/10.1016/j.jddst.2019.101205

A Formulation and Evaluation of Gastro-retentive In-Situ Gel of Anti-Ulcer Drug Misoprostol

Lucky Vasave

Shivraj Jadhav

Rushikesh Bachhav

Sunil Mahajan

Deepak Sonawane

Abstract

Keywords:

Most read articles by the same author(s)

Similar Articles

Lucky Vasave

Shivraj Jadhav

Rushikesh Bachhav

Sunil Mahajan

Deepak Sonawane